Impact of elexacaftor/tezacaftor/ivacaftor on microbiology and antibiotic utilization in people with cystic fibrosis.
March 1, 2025
Williams CL, Billings J, McGowan H, McDevitt R, Esther Jr CR, McKinzie CJ, Wilson WS, Kam CW. Pediatr Pulmonol. 2025 Mar;60(3):e71038. doi: 10.1002/ppul.71038. PMID: 40067072